Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 207

1.

T cells are required for the production of blister-inducing autoantibodies in experimental epidermolysis bullosa acquisita.

Sitaru AG, Sesarman A, Mihai S, Chiriac MT, Zillikens D, Hultman P, Solbach W, Sitaru C.

J Immunol. 2010 Feb 1;184(3):1596-603. doi: 10.4049/jimmunol.0901412. Epub 2009 Dec 28.

2.

Induction of complement-fixing autoantibodies against type VII collagen results in subepidermal blistering in mice.

Sitaru C, Chiriac MT, Mihai S, Büning J, Gebert A, Ishiko A, Zillikens D.

J Immunol. 2006 Sep 1;177(5):3461-8.

3.

The alternative pathway of complement activation is critical for blister induction in experimental epidermolysis bullosa acquisita.

Mihai S, Chiriac MT, Takahashi K, Thurman JM, Holers VM, Zillikens D, Botto M, Sitaru C.

J Immunol. 2007 May 15;178(10):6514-21.

4.

Binding of avian IgY to type VII collagen does not activate complement and leucocytes and fails to induce subepidermal blistering in mice.

Sesarman A, Mihai S, Chiriac MT, Olaru F, Sitaru AG, Thurman JM, Zillikens D, Sitaru C.

Br J Dermatol. 2008 Mar;158(3):463-71. doi: 10.1111/j.1365-2133.2007.08388.x. Epub 2008 Jan 17.

PMID:
18205879
5.

Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid.

Shimanovich I, Mihai S, Oostingh GJ, Ilenchuk TT, Bröcker EB, Opdenakker G, Zillikens D, Sitaru C.

J Pathol. 2004 Dec;204(5):519-27.

PMID:
15538734
6.
7.

Passive transfer of autoantibodies from a patient with mutilating epidermolysis bullosa acquisita induces specific alterations in the skin of neonatal mice.

Borradori L, Caldwell JB, Briggaman RA, Burr CE, Gammon WR, James WD, Yancey KB.

Arch Dermatol. 1995 May;131(5):590-5.

PMID:
7741548
8.

Induction of dermal-epidermal separation in mice by passive transfer of antibodies specific to type VII collagen.

Sitaru C, Mihai S, Otto C, Chiriac MT, Hausser I, Dotterweich B, Saito H, Rose C, Ishiko A, Zillikens D.

J Clin Invest. 2005 Apr;115(4):870-8.

9.

Complement-fixing anti-type VII collagen antibodies are induced in Th1-polarized lymph nodes of epidermolysis bullosa acquisita-susceptible mice.

Hammers CM, Bieber K, Kalies K, Banczyk D, Ellebrecht CT, Ibrahim SM, Zillikens D, Ludwig RJ, Westermann J.

J Immunol. 2011 Nov 15;187(10):5043-50. doi: 10.4049/jimmunol.1100796. Epub 2011 Oct 3.

10.

Epidermolysis bullosa acquisita: what's new?

Ishii N, Hamada T, Dainichi T, Karashima T, Nakama T, Yasumoto S, Zillikens D, Hashimoto T.

J Dermatol. 2010 Mar;37(3):220-30. doi: 10.1111/j.1346-8138.2009.00799.x. Review.

PMID:
20507385
11.

Induction of experimental epidermolysis bullosa acquisita by immunization with murine collagen VII.

Sesarman A, Sitaru C.

Methods Mol Biol. 2013;961:371-87. doi: 10.1007/978-1-62703-227-8_25.

PMID:
23325658
12.

B cells, dendritic cells, and macrophages are required to induce an autoreactive CD4 helper T cell response in experimental epidermolysis bullosa acquisita.

Iwata H, Bieber K, Tiburzy B, Chrobok N, Kalies K, Shimizu A, Leineweber S, Ishiko A, Vorobyev A, Zillikens D, Köhl J, Westermann J, Seeger K, Manz R, Ludwig RJ.

J Immunol. 2013 Sep 15;191(6):2978-88. doi: 10.4049/jimmunol.1300310. Epub 2013 Aug 19.

13.

Experimental models of epidermolysis bullosa acquisita.

Sitaru C.

Exp Dermatol. 2007 Jun;16(6):520-31. Review.

14.

Recombinant human IgA1 and IgA2 autoantibodies to type VII collagen induce subepidermal blistering ex vivo.

Recke A, Trog LM, Pas HH, Vorobyev A, Abadpour A, Jonkman MF, van Zandbergen G, Kauderer C, Zillikens D, Vidarsson G, Ludwig RJ.

J Immunol. 2014 Aug 15;193(4):1600-8. doi: 10.4049/jimmunol.1400160. Epub 2014 Jul 14.

15.

A patient with both bullous pemphigoid and epidermolysis bullosa acquisita: an example of intermolecular epitope spreading.

Fairley JA, Woodley DT, Chen M, Giudice GJ, Lin MS.

J Am Acad Dermatol. 2004 Jul;51(1):118-22.

PMID:
15243536
16.

Autoantibody-induced intestinal inflammation and weight loss in experimental epidermolysis bullosa acquisita.

Ishii N, Recke A, Mihai S, Hirose M, Hashimoto T, Zillikens D, Ludwig RJ.

J Pathol. 2011 Jun;224(2):234-44. doi: 10.1002/path.2857. Epub 2011 Mar 7.

PMID:
21381035
17.

Pathogenesis of epidermolysis bullosa acquisita, an autoimmune subepidermal bullous disease.

Hashimoto T, Ishii N, Ohata C, Furumura M.

J Pathol. 2012 Sep;228(1):1-7. doi: 10.1002/path.4062. Epub 2012 Jul 26.

PMID:
22692770
18.

Clearance rates of circulating and tissue-bound autoantibodies to type VII collagen in experimental epidermolysis bullosa acquisita.

Kasperkiewicz M, Hirose M, Recke A, Schmidt E, Zillikens D, Ludwig RJ.

Br J Dermatol. 2010 May;162(5):1064-70. doi: 10.1111/j.1365-2133.2010.09680.x. Epub 2010 Mar 4.

PMID:
20222918
19.

Persistent autoantibody-production by intermediates between short-and long-lived plasma cells in inflamed lymph nodes of experimental epidermolysis bullosa acquisita.

Tiburzy B, Szyska M, Iwata H, Chrobok N, Kulkarni U, Hirose M, Ludwig RJ, Kalies K, Westermann J, Wong D, Manz RA.

PLoS One. 2013 Dec 26;8(12):e83631. doi: 10.1371/journal.pone.0083631. eCollection 2013.

20.

Conditional depletion of mast cells has no impact on the severity of experimental epidermolysis bullosa acquisita.

Kasprick A, Yu X, Scholten J, Hartmann K, Pas HH, Zillikens D, Ludwig RJ, Petersen F.

Eur J Immunol. 2015 May;45(5):1462-70. doi: 10.1002/eji.201444769. Epub 2015 Mar 12.

Supplemental Content

Support Center